Symbol="ATHA"
AssetType="Common Stock"
Name="Athira PharmaÂ Inc"
Description="Athira Pharma, Inc., a late-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and stop neurodegradation. The company is headquartered in Bothell, Washington."
CIK="1620463"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="86764000"
EBITDA="-107520000"
PERatio="None"
PEGRatio="None"
BookValue="4.861"
DividendPerShare="0"
DividendYield="0"
EPS="-2.61"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.271"
ReturnOnEquityTTM="-0.463"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.61"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="8.2"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.473"
EVToRevenue="-"
EVToEBITDA="1.15"
Beta="2.773"
num_52WeekHigh="4.41"
num_52WeekLow="2.21"
num_50DayMovingAverage="2.835"
num_200DayMovingAverage="2.998"
SharesOutstanding="38054600"
DividendDate="None"
ExDividendDate="None"
symbol="ATHA"
open="2.31"
high="2.32"
low="2.22"
price="2.23"
volume="158933.00"
latest_trading_day="2023-08-31"
previous_close="2.28"
change="-0.05"
change_percent="-2.1930%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="46"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="54"
Volume_recent_avg="230626"
Change_recent_avg="-0.01"
Delta_recent_avg="0.14"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.5"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_10"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="54"
Aroon_momentum_negative="46"
image_negative_thumbnail_id_1="515"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0090.jpeg"
image_negative_thumbnail_id_2="130"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0046.jpeg"
image_neutral_thumbnail_id_1="580"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0019.jpeg"
image_neutral_thumbnail_id_2="569"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_positive_thumbnail_id_1="961"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0123.jpeg"
image_positive_thumbnail_id_2="609"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0099.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1177"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
